# Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

> **NCT03975153** · PHASE2 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 15 (actual)

## Conditions studied

- Pityriasis Rubra Pilaris

## Interventions

- **BIOLOGICAL:** guselkumab

## Key facts

- **NCT ID:** NCT03975153
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-03
- **Primary completion:** 2022-08-11
- **Final completion:** 2024-03-22
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975153, "Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03975153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*